首页> Biomedicines> Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma.

Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sama,Shamloo

第一单位： Chemical Genomics Centre of the Max Planck Society, 44227 Dortmund, Germany.;Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany.

作者： Sama,Shamloo ^[1] ; Andreas,Kloetgen ^[2] ; Stavroula,Petroulia ^[1] ; Kathryn,Hockemeyer ^[2] ; Sonja,Sievers ^[3] ; Aristotelis,Tsirigos ^[4] ; Ioannis,Aifantis ^[2] ; Jochen,Imig ^[5]

作者单位： Chemical Genomics Centre of the Max Planck Society, 44227 Dortmund, Germany.;Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany. ^[1] Department of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA.;Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA. ^[2] Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany.;Compound Management and Screening Center, 44227 Dortmund, Germany. ^[3] Department of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA.;Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA.;Applied Bioinformatics Laboratories, Office of Science and Research, New York University School of Medicine, New York, NY 10016, USA. ^[4] Chemical Genomics Centre of the Max Planck Society, 44227 Dortmund, Germany.;Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany.;Department of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA.;Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA. ^[5]

关键词 CRISPR activation drug resistance lncRNA melanoma small molecule inhibitor

DOI 10.3390/biomedicines11072054

PMID 37509693

发布时间 2025-01-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomedicines

2023年11卷7期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Biomedicines

2023年11卷7期

检索历史清除

Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma.

Biomedicines

相似文献

同项目论文

Biomedicines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma.

Biomedicines

相似文献

同项目论文

Biomedicines

相关期刊

检索历史清除